Pharminox Ltd.
http://www.pharminox.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Pharminox Ltd.
Pharminox acquires telomere licence from Cancer Research UK
Cancer Research UK has granted an exclusive global licence to Pharminox for its programme that targets telomeres and the enzyme that maintains them, telomerase.
Emergings in Brief (10/02)
Start-Up showcases the following recently launched companies: Hemocellular Development Corp., Immunetrics Inc., Pharminox Ltd. and Predictive Technology Inc.
IP2IPO Ltd.
IP2IPO Ltd. aims to facilitate technology transfer from UK universities, securing funding and advice to help commercialize intellectual property (IP).
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice